Edition:
United Kingdom

People: Grifols SA (GRLSbn.MC)

GRLSbn.MC on Madrid SE C.A.T.S.

16.26EUR
9:32am BST
Change (% chg)

€-0.20 (-1.22%)
Prev Close
€16.46
Open
€16.34
Day's High
€16.48
Day's Low
€16.26
Volume
10,121
Avg. Vol
107,577
52-wk High
€21.30
52-wk Low
€15.60

Grifols Deu, Victor 

Mr. Victor Grifols Deu serves as Co-Chief Executive Officer, Executive Director of Grifols, S.A. since January 1, 2017. He joined the Company in 2001 as an analyst in the Planning and Control Department of the Company. In 2008 he became the director of the Planning and Control Department and was also appointed member of the Executive Committees. He has been part of the team that analysed and was responsible for the integration of the operations after the acquisition of Alpha Therapeutics, Talecris Biotherapeutics and Novartis' Transfusion Diagnostic Unit. Mr. Grifols Deu is a member of the board of Araclon Biotech S.L.. He obtained graduation degree in Business Administration and Management from the Universitat Ramon Llull – Sarrià Chemical Institute and holds a postgraduate degree in Business Administration and Management from Michael Smurfit Business School in Dublin.

Basic Compensation

Total Annual Compensation, EUR 450,000
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR 114,000
Fiscal Year Total, EUR 564,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --